Dr. Julia McNeice, DO

Dr. McNeice practices at Watson Clinic in Lakeland, Florida.

Dr. McNeice's NPI, 1003308222, was assigned on June 4, 2018. Dr. McNeice graduated from Arizona College of Osteopathic Medicine - Glendale in 2018. Dr. McNeice holds Florida license OS18057.

Dr. McNeice's primary practice is Watson Clinic, at 1430 Lakeland Hills Blvd, Lakeland, FL 33805 in Polk County. The practice phone is (863) 680-7700.

Dr. McNeice's primary practice is Watson Clinic in Lakeland, Florida. The medical group on file is Watson Clinic. Dmand AI also links Dr. McNeice to 2 more home health agencies, 1 group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McNeice practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. McNeice's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. McNeice is board certified in internal medicine by the American Board of Internal Medicine. Dr. McNeice is licensed in Florida.

Dmand AI lists acid reflux, acute gastroduodenitis, acute sinusitis, acute skin infection, adjustment disease, alcohol use disorders, aneurysm and anxiety among the conditions Dr. McNeice treats.

CMS data shows 945 Medicare services from Dr. McNeice across 11 procedure codes in 2024, for 216 Medicare patients. Medicare paid $71,812 for them. Every service was in an office.

CMS counts 216 Medicare patients who saw Dr. McNeice in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high cholesterol, and 68% have high blood pressure. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McNeice's median patient age at 67, with 76% women.

In 2024, Dr. McNeice wrote 6,350 Medicare Part D claims for 442 patients. 84% of them were for generic drugs. CMS names the drug for 5,679 of them, across 108 drugs with 11 or more claims each, at $569,431 in total drug cost. In 2023, CMS named 4,776 claims across 105 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. McNeice for performance year 2024, reported through an alternative payment model (APM). Dr. McNeice accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McNeice as offering telehealth.

CMS Open Payments shows 283 general payments to Dr. McNeice from 30 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $1,018.

Dr. McNeice serves on GME Ambassador Committee and Resident Advisor Commitee.

Dr. McNeice graduated from Arizona College of Osteopathic Medicine - Glendale in 2018. Dr. McNeice is a member of AMA and AOA.

Dr. McNeice is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.